BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31338849)

  • 1. Concomitant GNA11 and SF3B1 mutations in two cases of melanoma associated with blue naevus.
    Danset M; Milley S; Harou O; Vasseur D; Amini-Adle M; Thomas L; Dalle S; Balme B; Lopez J
    Clin Exp Dermatol; 2020 Jan; 45(1):123-126. PubMed ID: 31338849
    [No Abstract]   [Full Text] [Related]  

  • 2. SF3B1 and BAP1 mutations in blue nevus-like melanoma.
    Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D
    Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic and mutational analysis of a case of blue nevus-like melanoma.
    Dai J; Tetzlaff MT; Schuchter LM; Elder DE; Elenitsas R
    J Cutan Pathol; 2016 Sep; 43(9):776-80. PubMed ID: 27152652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
    Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
    Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma Ex Blue Nevus With GNA11 Mutation and BAP1 Loss: Case Report and Review of the Literature.
    Chang LW; Kazlouskaya V; Kazi R; Davar D; Ferris RL; Ho J; Karunamurthy A; Jedrych JJ; Bunimovich YL
    Am J Dermatopathol; 2020 Nov; 42(11):854-857. PubMed ID: 32310862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum.
    Johnson DB; Roszik J; Shoushtari AN; Eroglu Z; Balko JM; Higham C; Puzanov I; Patel SP; Sosman JA; Woodman SE
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):470-3. PubMed ID: 27089234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNA11-mutated and BAP1-negative Melanomas Ex Blue Naevi: A Particularly Aggressive Entity.
    Uguen A; Guibourg B; Costa S; Marcorelles P
    Acta Derm Venereol; 2017 Jun; 97(6):743-744. PubMed ID: 27990554
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
    Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
    Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
    Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
    Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
    Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma arising in extracutaneous cellular blue naevus: report of two cases with comparison to cutaneous counterparts and uveal melanoma.
    Jo VY; Russell-Goldman E; Yoon CH; Doyle LA; Hanna J
    Histopathology; 2022 Nov; 81(5):625-634. PubMed ID: 35941700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report.
    Patel SP; Kim DW; Lacey CL; Hwu P
    Medicine (Baltimore); 2016 Jan; 95(4):e2336. PubMed ID: 26825879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcome.
    Held L; Metzler G; Eigentler TK; Leiter U; Messina J; Gogel J; Bauer J; Garbe C
    J Cutan Pathol; 2012 Dec; 39(12):1088-93. PubMed ID: 23046118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound blue nevus: a reappraisal of the concept in the genomic era.
    Jaquemus J; Perron E; Buisson A; Ferrara G; Haddad V; de la Fouchardiere A
    Virchows Arch; 2020 Mar; 476(3):439-443. PubMed ID: 31754815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases.
    Shah K; Folpe AL; Miller M; Morgan JA; Raut CP; Doyle LA
    Histopathology; 2021 Jan; 78(2):281-289. PubMed ID: 32698251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.
    Van Raamsdonk CD; Bezrookove V; Green G; Bauer J; Gaugler L; O'Brien JM; Simpson EM; Barsh GS; Bastian BC
    Nature; 2009 Jan; 457(7229):599-602. PubMed ID: 19078957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking the guesswork out of uveal melanoma.
    Herlyn M; Nathanson KL
    N Engl J Med; 2010 Dec; 363(23):2256-7. PubMed ID: 21083377
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi.
    Emley A; Nguyen LP; Yang S; Mahalingam M
    Hum Pathol; 2011 Jan; 42(1):136-40. PubMed ID: 21056896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.
    Rose AM; Luo R; Radia UK; Kalirai H; Thornton S; Luthert PJ; Jayasena CN; Verity DH; Coupland SE; Rose GE
    BMC Cancer; 2018 Dec; 18(1):1262. PubMed ID: 30558566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.